- ►annals.org [PDF] M Verhovsek, JD Douketis, Q Yi, S Shrivastava … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: The optimal duration of anticoagulation for a first episode of
unprovoked venous thromboembolism (VTE) is uncer- tain. Methods for predicting
risk for recurrence may identify low- risk patients who are less likely to ... Cited by 17 - Related articles - All 7 versions
- ►hematologylibrary.org S Siragusa, A Malato, R Anastasio, V Cigna, G … - Blood, 2008 - bloodjournal.hematologylibrary.org Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for
evaluating the optimal duration of oral anticoagulant treatment (OAT). Patients
with a first episode of deep vein thrombosis, treated with OAT for 3 ... Cited by 17 - Related articles - All 23 versions
A Tripodi, C Legnani, V Chantarangkul, B … - Journal of Thrombosis and Haemostasis, 2008 - interscience.wiley.com Summary. Background: The assessment of the risk of recurrent venous
thromboembolism (VTE) is important to determine the optimal duration of
secondary prophylaxis. The risk can be estimated by measuring individual ... Cited by 13 - Related articles - All 5 versions
- ►ecmaj.com MA Rodger, SR Kahn, PS Wells, DA Anderson, … - Canadian Medical Association Journal, 2008 - Can Med Assoc V enous thromboembolism is a common, potentially fatal, yet treatable,
condition. The risk of a recurrent venous thromboembolic event after 3–6
months of oral anticoagulant therapy varies. Some groups of patients (eg, ... Cited by 19 - Related articles - All 51 versions
B Cosmi, C Legnani, M Cini, E Favaretto, G … - Thrombosis Research, 2008 - Elsevier Background and objectives: To assess the predictive value of D-dimer (Dd) and
Factor VIII (FVIII) in combination for recurrent venous thromboembolism (VTE)
after vitamin K antagonist (VKA) therapy suspension. Design and methods: ... Cited by 7 - Related articles - All 39 versions
M Besser, C Baglin, R Luddington, A van … - J Thromb Haemost, 2008 - interscience.wiley.com Summary. Objective: To determine the predictive value of measurement of
parameters of thrombin generation for unprovoked recurrent venous thrombosis.
Methods: Measurements were made of thrombin generation in a prospective ... Cited by 16 - Related articles - All 3 versions
- ►uniklinikum-jena.de [PDF] S Eichinger, G Hron, M Kollars, PA Kyrle - Clinical Chemistry, 2008 - Am Assoc Clin Chem Background: Increased thrombin generation is associated with an increased risk
of recurrent venous thromboembolism. We investigated the relation between
endogenous thrombin potential (ETP) and risk of recurrent venous ... Cited by 11 - Related articles - All 7 versions
[CITATION] Predicting risk of recurrent venous thrombosis using a 5-point scoring system including …
E Bruinstroop, FA Klok, REE VAN DE, FL … - Journal of Thrombosis and Haemostasis, 2009 - interscience.wiley.com Background: The evidence on the optimal duration of treatment in patients with
an idiopathic venous thromboembolic event (VTE) is inconclusive. D-dimer testing
to predict recurrent VTE has been evaluated in several studies. Objectives: ... Cited by 2 - Related articles - All 5 versions
[CITATION] Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant …
